IRIS Accounts Production v25.2.0.378 04163487 Board of Directors 1.5.24 30.4.25 30.4.25 false true false false true false Ordinary shares 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh041634872024-04-30041634872025-04-30041634872024-05-012025-04-30041634872023-04-30041634872023-05-012024-04-30041634872024-04-3004163487ns15:EnglandWales2024-05-012025-04-3004163487ns14:PoundSterling2024-05-012025-04-3004163487ns10:Director12024-05-012025-04-3004163487ns10:PrivateLimitedCompanyLtd2024-05-012025-04-3004163487ns10:SmallEntities2024-05-012025-04-3004163487ns10:AuditExempt-NoAccountantsReport2024-05-012025-04-3004163487ns10:SmallCompaniesRegimeForDirectorsReport2024-05-012025-04-3004163487ns10:SmallCompaniesRegimeForAccounts2024-05-012025-04-3004163487ns10:FullAccounts2024-05-012025-04-3004163487ns10:OrdinaryShareClass12024-05-012025-04-3004163487ns10:Director22024-05-012025-04-3004163487ns10:CompanySecretary12024-05-012025-04-3004163487ns10:RegisteredOffice2024-05-012025-04-3004163487ns5:CurrentFinancialInstruments2025-04-3004163487ns5:CurrentFinancialInstruments2024-04-3004163487ns5:Non-currentFinancialInstruments2025-04-3004163487ns5:Non-currentFinancialInstruments2024-04-3004163487ns5:ShareCapital2025-04-3004163487ns5:ShareCapital2024-04-3004163487ns5:RetainedEarningsAccumulatedLosses2025-04-3004163487ns5:RetainedEarningsAccumulatedLosses2024-04-3004163487ns5:PlantMachinery2024-05-012025-04-3004163487ns5:LandBuildings2024-04-3004163487ns5:PlantMachinery2024-04-3004163487ns5:LandBuildings2024-05-012025-04-3004163487ns5:LandBuildings2025-04-3004163487ns5:PlantMachinery2025-04-3004163487ns5:LandBuildings2024-04-3004163487ns5:PlantMachinery2024-04-3004163487ns5:LeasedAssetsHeldAsLesseens5:PlantMachinery2024-05-012025-04-3004163487ns5:LeasedAssetsHeldAsLesseens5:PlantMachinery2025-04-3004163487ns5:WithinOneYearns5:CurrentFinancialInstruments2025-04-3004163487ns5:WithinOneYearns5:CurrentFinancialInstruments2024-04-3004163487ns10:OrdinaryShareClass12025-04-30
REGISTERED NUMBER: 04163487 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 30TH APRIL 2025

FOR

HODGSON PHARMACY LIMITED

HODGSON PHARMACY LIMITED (REGISTERED NUMBER: 04163487)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30TH APRIL 2025










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


HODGSON PHARMACY LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30TH APRIL 2025







DIRECTORS: Mr D C Patel
Mr A D Patel



SECRETARY: Mr D C Patel



REGISTERED OFFICE: 59 Station Road
Longfield
Kent
DA3 7QA



REGISTERED NUMBER: 04163487 (England and Wales)



BANKERS: National Westminster Bank plc
12 High Street
Dartford
Kent
DA1 1DD

HODGSON PHARMACY LIMITED (REGISTERED NUMBER: 04163487)

BALANCE SHEET
30TH APRIL 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 199,836 127,288

CURRENT ASSETS
Stocks 98,381 83,708
Debtors 5 74,053 35,970
Cash at bank and in hand 347,327 324,584
519,761 444,262
CREDITORS
Amounts falling due within one year 6 302,534 324,128
NET CURRENT ASSETS 217,227 120,134
TOTAL ASSETS LESS CURRENT
LIABILITIES

417,063

247,422

CREDITORS
Amounts falling due after more than one year 7 (79,089 ) -

PROVISIONS FOR LIABILITIES (47,000 ) (47,000 )
NET ASSETS 290,974 200,422

CAPITAL AND RESERVES
Called up share capital 8 20,000 20,000
Retained earnings 270,974 180,422
SHAREHOLDERS' FUNDS 290,974 200,422

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30th April 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30th April 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 3rd October 2025 and were signed on its behalf by:





Mr D C Patel - Director


HODGSON PHARMACY LIMITED (REGISTERED NUMBER: 04163487)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30TH APRIL 2025


1. STATUTORY INFORMATION

Hodgson Pharmacy Limited is a private company, limited by shares, registered in England and Wales. The company's registered number is 04163487 and registered office address is 59 Station Road, Longfield, Kent, DA3 7QA.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Plant and machinery etc - 15% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 13 (2024 - 10 ) .

HODGSON PHARMACY LIMITED (REGISTERED NUMBER: 04163487)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30TH APRIL 2025


4. TANGIBLE FIXED ASSETS
Plant and
Land and machinery
buildings etc Totals
£    £    £   
COST
At 1st May 2024 29,286 520,283 549,569
Additions - 123,751 123,751
At 30th April 2025 29,286 644,034 673,320
DEPRECIATION
At 1st May 2024 24,467 397,814 422,281
Charge for year 723 50,480 51,203
At 30th April 2025 25,190 448,294 473,484
NET BOOK VALUE
At 30th April 2025 4,096 195,740 199,836
At 30th April 2024 4,819 122,469 127,288

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:

Plant and
machinery
etc
£   
COST
Additions 112,776
At 30th April 2025 112,776
DEPRECIATION
Charge for year 28,193
At 30th April 2025 28,193
NET BOOK VALUE
At 30th April 2025 84,583

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade debtors 45,785 8,052
Other debtors 28,268 27,918
74,053 35,970

HODGSON PHARMACY LIMITED (REGISTERED NUMBER: 04163487)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30TH APRIL 2025


6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Hire purchase contracts 14,668 -
Trade creditors 236,893 228,092
Taxation and social security 22,541 30,159
Other creditors 28,432 65,877
302,534 324,128

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2025 2024
£    £   
Hire purchase contracts 79,089 -

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2025 2024
value: £    £   
20,000 Ordinary shares £1 20,000 20,000

9. RELATED PARTY DISCLOSURES

The company paid £12,000 (2024: £12,000) as rent to Mr D.C. Patel. An amount of £1,695 (2024: £41,695 ) was due to Mr D C Patel at the year end.

10. ULTIMATE CONTROLLING PARTY

The company was under the control of the director and majority shareholder, Mr D.C. Patel throughout the current year and previous period.